Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) Didanosine, Lamivudine, and Tenofovir
Salvato in:
Baker, J., ET AL., Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) Didanosine, Lamivudine, and Tenofovir. American Journal on Addictions, Vol. 19, no. 1 (2010), p. 17-29.
Ref.
185665
Localizzazione:
SIIS R.1264 Archivo
Palabras clave:
Buprenorfina, Diagnóstico dual, Drogodependencias, Enfermedades infecciosas, Estudio epidemiológico, Fármacos, Interacción, Opiáceos, Programas de mantenimiento, Sida, Tratamiento
Buprenorfina, Diagnóstico dual, Drogodependencias, Enfermedades infecciosas, Estudio epidemiológico, Fármacos, Interacción, Opiáceos, Programas de mantenimiento, Sida, Tratamiento
Documenti analoghi: Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) Didanosine, Lamivudine, and Tenofovir
- Effect of cocaine use on buprenorphine pharmacokinetics in humans
- Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review
- Lack of clinically significant drug interactions between nevirapine and buprenorphine
- SELF REPORTED SIDE EFFECTSIN BUPRENORPHINE AND METHADONE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY: RESULTS FROM THE MANIF 2000 COHORT STUDY
- Benzodiazepines, methadone and buprenorphine: interactions and clinical management
- QUELQUES IDEES SUR L'INTEGRATION